Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community how about progesterone cream?

      in Research/Science  22 upvotes 5 months ago
      Progesterone cream might help with hair loss by inhibiting DHT production and suppressing prolactin, which can increase DHT. Some dermatologists have used progesterone for hair loss treatment, and it has been effective, sometimes combined with minoxidil, finasteride, and hydrocortisone.

      community Stop expecting results in 2 months!

      in Treatment  125 upvotes 5 months ago
      People discussing hair loss treatments emphasize the need for patience, as results from using finasteride and minoxidil can take 8-12 months or longer. Some users report early signs of improvement, while others experience continued shedding or slower progress.

      community 4.5 months progress at age 26.

      in Progress Pictures  159 upvotes 6 months ago
      A 26-year-old has seen hair regrowth in 4.5 months using oral finasteride, topical minoxidil, and recently RU58841 on the temples. Suggestions include adding weekly microneedling to improve results.

      community I’m over it. So glad to not worry about hair anymore.

      in Shaved/buzzed  569 upvotes 6 months ago
      A user shared their positive experience with shaving their head, feeling liberated from worrying about hair loss. Some discussed their own hair loss treatments, including finasteride, oral minoxidil, and Rogaine, while others expressed support for the shaved look.

      community Year and a half finasteride only

      in Progress Pictures  293 upvotes 6 months ago
      A user shared their positive experience with thicker hair and improved confidence after a year and a half of using finasteride without side effects. Specific treatments discussed include oral finasteride, with a question about the daily dosage.

      community GT20029 - Promising phase II results

      in Research/Science  16 upvotes 6 months ago
      GT20029 showed significant hair growth and safety in phase II trials, with no adverse sexual events. Users are hopeful but concerned about future costs and systemic effects.